IC
HUMA icon

IEQ Capital’s Humacyte HUMA Stock Holding History

IEQ Capital’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Buy
279,052
+14,733
+6% +$13.7K ﹤0.01% 1802
2026
Q1 		$160K Buy
+264,319
New +$275K ﹤0.01% 1742
2025
Q3 		– Sell
-91,896
Closed -$192K – 1955
2025
Q2 		$192K Buy
+91,896
New +$177K ﹤0.01% 1621

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

IEQ Capital's HUMA Position: Q2 2026 in Review

IEQ Capital increased its Humacyte (HUMA) stake by 5.6% in Q2 2026, buying an estimated $13.7K and bringing the position to 279,052 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #1802.

IEQ Capital first reported a position in HUMA in Q2 2025 and has held it in 3 quarters since. 163 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • IEQ Capital held 279,052 shares of Humacyte worth $218K as of Q2 2026.
  • IEQ Capital bought 14,733 Humacyte shares in Q2 2026, an estimated $13.7K.
  • Humacyte made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1802 holding.
  • IEQ Capital first reported a position in Humacyte in Q2 2025 and has held it in 3 quarters since.
  • 163 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.